Taken together, these results suggest that selective deletion of Shp2 in KCs generated a protumorigenic niche in the liver, which was sufficient to aggravate tumor progression from metastasized tumor cells, but was insufficient to promote initiation and development of primary liver cancer driven by the oncogenes Ras and Myc. The gene discussed is MYC; the disease is liver cancer.